 鲜花( 85)  鸡蛋( 2)
|

楼主 |
发表于 2015-2-28 21:48
|
显示全部楼层
Stock soars after Cold-fX wins crucial approval6 j1 L# ~5 g* D
& E6 R, }2 O$ U3 n3 @
EDMONTON - CV Technologies Inc. shares rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.% L* Y" a+ x4 c
, R! o0 h$ f% }* g7 hBY THE EDMONTON JOURNAL FEBRUARY 16, 2007
& h m9 y$ r& w' j" g! k' f 6 Q) H$ k: m; N+ R
/ M' g( ]8 |+ o4 h0 kEDMONTON - CV Technologies Inc. SHARES rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.
" W6 L6 O4 U3 N- @; M9 t6 ` S: x9 N* E. }7 `
The agency said CV Technologies can continue to market Cold-fX as helping "to reduce the frequency, severity and duration of cold and flu symptoms by boosting the IMMUNE SYSTEM."
) E# W. P7 B! N1 G
/ w2 A2 V2 k. bThe APPROVAL follows a review of seven clinical trials and more than 10 years of research about the product.2 ~+ L$ |/ b1 k$ K* a
# C) }1 {& M4 M! h1 Z. _6 W
It should create even more confidence among consumers and medical professionals that the product works, CEO Jacqueline Shan said Thursday.! q. [# e5 s* V" R& o" f; V+ t
) s0 r, ~- V1 i! b$ f k% j* u, k
It certainly instilled confidence in the market, as shares closed at $2.90 on THE TORONTO STOCK EXCHANGE, up $1.08 on a volume of 4.6 million.
. j1 l; S* S# M; }7 i3 |1 u3 T1 Y( x, c$ c6 \
"As a scientist, it's one of the highlights of my CAREER," Shan said.# ]6 R4 ]" e6 k1 V
' n7 X" B6 I2 f% Y6 h& G, i8 \4 G7 o: C
"This approval is a breakthrough in realizing our vision of being a global leader in developing products for disease prevention."
4 W: h7 T. J9 f* ?) P. i, H- j: I6 a0 P
It's Cold-fX's strongest medical recognition to date, said Shan. It means the company can advertise the HEALTH BENEFITS more effectively to consumers and health professionals, she said.( v! y: i- n2 C( y/ \$ G8 O
( s t( L( q5 K+ X
Ginseng-based Cold-fX is already the top-selling cold and flu treatment in Canada, but Shan said there is plenty of room for more growth.9 Y9 s$ G& H( D" ]
6 A9 F& {( j" `* W1 jThe approval will also help raise the product's PROFILE in the lucrative U.S. market, which Cold-fX entered in October. The move came with a new marketing push, using former Oilers superstar Mark Messier as its spokesman.: D! [7 _' f4 i& D" B. M
+ m) y" ^5 M- h' Z
8 [2 Y; ]% m, Yhttp://www.canada.com/story.html ... 9-be80-f40f1426f662 |
|